Beverly Hills Private Wealth’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4,212
Closed -$318K – 333
2026
Q1
$318K Buy
4,212
+244
+6% +$17.4K 0.05% 259
2025
Q4
$245K Buy
3,968
+31
+0.8% +$1.82K 0.04% 285
2025
Q3
$231K Buy
+3,937
New +$229K 0.04% 308
2024
Q2
– Sell
-4,230
Closed -$230K – 362
2024
Q1
$230K Sell
4,230
-30
-0.7% -$1.56K 0.05% 316
2023
Q4
$240K Sell
4,260
-385
-8% -$21.8K 0.06% 293
2023
Q3
$288K Sell
4,645
-5,018
-52% -$317K 0.09% 233
2023
Q2
$633K Buy
9,663
+4,840
+100% +$308K 0.1% 206
2023
Q1
$356K Buy
4,823
+432
+10% +$33.3K 0.11% 200
2022
Q4
$321K Buy
+4,391
New +$347K 0.14% 169

Other funds holding NTR

Beverly Hills Private Wealth's NTR Position: Q2 2026 in Review

Beverly Hills Private Wealth sold out of Nutrien (NTR) in Q2 2026, closing a stake of 4,212 shares — an estimated $318K sold.

Beverly Hills Private Wealth first reported a position in NTR in Q4 2022 and held it in 9 quarters. The position peaked at $633K in Q2 2023. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Beverly Hills Private Wealth reported no remaining Nutrien position as of Q2 2026 after selling out during the quarter.
  • Beverly Hills Private Wealth sold 4,212 Nutrien shares in Q2 2026, an estimated $318K.
  • Beverly Hills Private Wealth first reported a position in Nutrien in Q4 2022 and held it in 9 quarters.
  • Beverly Hills Private Wealth's Nutrien position peaked at $633K in Q2 2023.
  • 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Beverly Hills Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.